| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| EMR/ESD类(元) | - | - | - | 350,852,843.58 |
| ERCP类(元) | - | - | - | 172,867,213.23 |
| EUS/EBUS类(元) | - | - | - | 43,435,229.85 |
| 代理经销(元) | - | - | - | 89,766,525.63 |
| 活检类(元) | - | - | - | 246,847,332.07 |
| 可视化产品类(元) | 15,610,547.55 | 35,532,807.52 | 13,763,924.20 | 97,442,907.06 |
| 扩张类(元) | - | - | - | 212,146,612.11 |
| 微波消融针(元) | - | - | - | 174,037,165.88 |
| 止血及闭合类(元) | - | - | - | 921,370,029.89 |
| 肿瘤消融设备(元) | - | - | - | 12,137,558.01 |
| 内镜耗材类(元) | 1,217,844,483.73 | 2,327,970,304.98 | 1,127,451,114.07 | - |
| 肿瘤介入类(元) | 114,029,645.56 | 218,243,092.93 | 111,217,088.89 | - |
| 其他(元) | 206,234,720.25 | 159,539,785.62 | 77,828,140.16 | 74,752,335.75 |
| 营业成本(元) | ||||
| EMR/ESD类(元) | - | - | - | 131,591,277.57 |
| ERCP类(元) | - | - | - | 70,301,977.62 |
| EUS/EBUS类(元) | - | - | - | 26,990,052.01 |
| 代理经销(元) | - | - | - | 56,413,541.58 |
| 活检类(元) | - | - | - | 151,333,764.94 |
| 可视化产品类(元) | 13,219,659.54 | 17,557,442.79 | 6,752,040.30 | 62,199,412.34 |
| 扩张类(元) | - | - | - | 56,214,458.12 |
| 微波消融针(元) | - | - | - | 35,759,118.18 |
| 止血及闭合类(元) | - | - | - | 218,452,433.21 |
| 肿瘤消融设备(元) | - | - | - | 9,058,217.96 |
| 内镜耗材类(元) | 388,355,669.09 | 725,062,672.56 | 346,957,227.26 | - |
| 肿瘤介入类(元) | 33,708,159.77 | 51,079,087.16 | 29,569,002.84 | - |
| 其他(元) | 107,441,556.63 | 90,152,110.85 | 41,553,648.68 | 28,999,824.11 |
| 毛利(元) | ||||
| EMR/ESD类(元) | - | - | - | 219,261,566.01 |
| ERCP类(元) | - | - | - | 102,565,235.61 |
| EUS/EBUS类(元) | - | - | - | 16,445,177.84 |
| 代理经销(元) | - | - | - | 33,352,984.05 |
| 活检类(元) | - | - | - | 95,513,567.13 |
| 可视化产品类(元) | 2,390,888.01 | 17,975,364.73 | 7,011,883.90 | 35,243,494.72 |
| 扩张类(元) | - | - | - | 155,932,153.99 |
| 微波消融针(元) | - | - | - | 138,278,047.70 |
| 止血及闭合类(元) | - | - | - | 702,917,596.68 |
| 肿瘤消融设备(元) | - | - | - | 3,079,340.05 |
| 内镜耗材类(元) | 829,488,814.64 | 1,602,907,632.42 | 780,493,886.81 | - |
| 肿瘤介入类(元) | 80,321,485.79 | 167,164,005.77 | 81,648,086.05 | - |
| 其他(元) | 98,793,163.62 | 69,387,674.77 | 36,274,491.48 | 45,752,511.64 |
| 毛利率(%) | ||||
| EMR/ESD类(%) | - | - | - | 62.49 |
| ERCP类(%) | - | - | - | 59.33 |
| EUS/EBUS类(%) | - | - | - | 37.86 |
| 代理经销(%) | - | - | - | 37.16 |
| 活检类(%) | - | - | - | 38.69 |
| 可视化产品类(%) | 15.32 | 50.59 | 50.94 | 36.17 |
| 扩张类(%) | - | - | - | 73.50 |
| 微波消融针(%) | - | - | - | 79.45 |
| 止血及闭合类(%) | - | - | - | 76.29 |
| 肿瘤消融设备(%) | - | - | - | 25.37 |
| 内镜耗材类(%) | 68.11 | 68.85 | 69.23 | - |
| 肿瘤介入类(%) | 70.44 | 76.60 | 73.41 | - |
| 其他(%) | 47.90 | 43.49 | 46.61 | 61.21 |
| 收入构成(%) | ||||
| EMR/ESD类(%) | - | - | - | 14.65 |
| ERCP类(%) | - | - | - | 7.22 |
| EUS/EBUS类(%) | - | - | - | 1.81 |
| 代理经销(%) | - | - | - | 3.75 |
| 活检类(%) | - | - | - | 10.30 |
| 可视化产品类(%) | 1.00 | 1.30 | 1.03 | 4.07 |
| 扩张类(%) | - | - | - | 8.86 |
| 微波消融针(%) | - | - | - | 7.26 |
| 止血及闭合类(%) | - | - | - | 38.46 |
| 肿瘤消融设备(%) | - | - | - | 0.51 |
| 内镜耗材类(%) | 78.38 | 84.92 | 84.75 | - |
| 肿瘤介入类(%) | 7.34 | 7.96 | 8.36 | - |
| 其他(%) | 13.27 | 5.82 | 5.85 | 3.12 |
| 毛利构成(%) | ||||
| EMR/ESD类(%) | - | - | - | 14.16 |
| ERCP类(%) | - | - | - | 6.62 |
| EUS/EBUS类(%) | - | - | - | 1.06 |
| 代理经销(%) | - | - | - | 2.15 |
| 活检类(%) | - | - | - | 6.17 |
| 可视化产品类(%) | 0.24 | 0.97 | 0.77 | 2.28 |
| 扩张类(%) | - | - | - | 10.07 |
| 微波消融针(%) | - | - | - | 8.93 |
| 止血及闭合类(%) | - | - | - | 45.40 |
| 肿瘤消融设备(%) | - | - | - | 0.20 |
| 内镜耗材类(%) | 82.05 | 86.30 | 86.20 | - |
| 肿瘤介入类(%) | 7.94 | 9.00 | 9.02 | - |
| 其他(%) | 9.77 | 3.74 | 4.01 | 2.95 |